1 / 9

Poliomyelitis Global Clinical Trials Review, H1, 2018

Poliomyelitis is an extremely infectious viral disease, which majorly affects the young children. The virus is most common for attacking the nervous system and causing paralysis. In about 0.5% of cases there is muscle weakness resulting in an inability to move.

kenresearch23
Download Presentation

Poliomyelitis Global Clinical Trials Review, H1, 2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Surge In Global Clinical Trials For Poliomyelitis Market Outlook: Ken Research

  2. SUMMARY • Global Data's clinical trial report, Poliomyelitis Global Clinical Trials Review, H1, 2018 provides an overview of Poliomyelitis clinical trials scenario. This report provides top line data relating to the clinical trials on Poliomyelitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. • The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database – Pharma E-Track Clinical trials database. • *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

  3. POLIOMYELITIS • According to the report analysis, ‘Poliomyelitis Global Clinical Trials Review, H1, 2018’ suggests that some of the major companies and health care organization which are functioning in this sector with more efficiency and development in the treatment technologies includes glaxosmithklineplc, sanofi panacea biotec ltd, merck & co inc, international centre for diarrhoeal disease research, bangladeshmcm vaccine, bvbaddim health project, china national pharmaceuticals group corp, daiichisankyo co ltd, bharat biotech ltd, novartis. • Lurie comprehensive cancer center of northwestern university, fredhutchison cancer research center, European organization for research and treatment of cancer and others. Nevertheless, significant increase in the research and development, establishment in the government and non-government funding for rehabilitation development and others are the major growth drivers for the vaccines market of the poliomyelitis.

  4. POLIOMYELITIS • Poliomyelitis is an extremely infectious viral disease, which majorly affects the young children. The virus is most common for attacking the nervous system and causing paralysis. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to a few days. More often the weakness involves the legs but may less commonly involve the muscles of neck, diaphragm and head. • In certain cases many people fully recover but sometimes few percent of children and adults may die. The persons who are having symptoms of fever, headache, neck stiffness, a sore throat, pains in the legs and arms are usually back to normal within one or two weeks. No doubt the disease of poliomyelitis has existed from thousands of years ago but the treatment and current scenario has propel the significant growth in the treatment of poliomyelitis.

  5. POLIOMYELITIS • Geographically, many countries are working efficiently for eliminating the disease of Poliomyelitis mostly followed by china and Australia. Moreover, South America is also expected to dominate the significant share in this market. Geographically, the treatment of poliomyelitis has been spread across the globe which includes Asia-pacific region, Europe, North America, middle-east and Africa, central and South America. • The patients of poliomyelitis a portable ventilators be required a supportive instrument of breathing. In the recent trend many patients of polio with permanent respiratory paralysis use modern jacket-type negative-pressure ventilators worn over the chest and abdomen. • Therefore, with the more development in the technology and massive development in the economy has led to significant growth in the market in the coming years with more investment plans and new opportunities of the key players. .

  6. Browse Full Market Report • Poliomyelitis Global Clinical Trials Review, H1, 2018

  7. About ken research • Ken Research provides bespoke industry intelligence, equity research reports and business consulting services on gamut of sectors across the globe. We use advanced information management tools, sophisticated analytical systems and methodologies to help our clients with crucial industry information for decision making. • As a leading Online Market Research Report Seller, Ken Research act as a platform for accessing statistics, forecast, business insights, Ideas, concepts and much more.

  8. Contact Us: • Ken Research • Ankur Gupta, Head Marketing & Communications • sales@kenresearch.com • +91-9015378249

More Related